Online Radiotherapy Information Application

Öz

The aim of this study is to inform patients about the malfunction of the device on which radiotherapy is applied, the duration of treatment, the time of treatment, and to obtain disease-specific information. We provide real time information about the status of two external (linear accelerator), one internal (brachytherapy) RT devices and the computerized tomography (CT) simulator used for RT planning (operating/under maintenance/faulty), which we treat in our clinic. A 32-question survey regarding application satisfaction was conducted on 151 cases using the application, and the contribution of the application to the transportation time and cost and the patient's treatment compliance in patients receiving RT was investigated. 117 (77.5%) of 151 patients received curative RT and 34 (22.5%) received palliative RT. Median age is 55 (min:28, max:80). 102 (67.5%) patients stated that the application saved them time on the road and/or travel expenses. Among the questions asked, the highest scores were received by the questions "I am sufficiently informed about the use of the application", "I find the application sustainable" and "I recommend the application" with a mean of 4.58. Applications in radiation oncology are lacking in providing patient information in RT patients and sharing device information in order to prevent unnecessary transport, especially in cases where RT is applied. Instant information about RT devices and information specific to the patient's diagnosis are very important for patient treatment compliance, and applications need to be developed to improve it.

Anahtar Kelimeler

• mobile application
• radiotherapy
• device malfunction
• instant patient information

Online Radyoterapi Bilgilendirme Aplikasyonu

Öz

Bu çalışmanın amacı, hastalara radyoterapi (RT) uygulanan cihazın arızası, tedavi süresi, tedavi zamanı hakkında ve hastalığa özgü bilgi vermektir. Kliniğimizde tedavi ettiğimiz iki eksternal (lineer hızlandırıcı), bir internal (brakiterapi) RT cihazı ve RT planlamasında kullanılan bilgisayarlı tomografi (BT) simülatörünün (çalışıyor/bakım altında/arızalı) durumu hakkında gerçek zamanlı bilgi sağlanmıştır. Uygulamayı kullanan 151 vakaya uygulama memnuniyetine ilişkin 32 soruluk bir anket uygulanmış ve RT alan hastalarda uygulamanın ulaşım süresine, maliyetine ve hastanın tedaviye uyumuna katkısı araştırılmıştır. 151 hastanın 117'si (%77,5) küratif RT ve 34'ü (%22,5) palyatif RT almıştır. Ortanca yaş 55'tir (min:28, maks:80). 102 (%67,5) hasta, uygulamanın kendilerine yolda ve/veya seyahat masraflarında zaman kazandırdığını belirtmiştir. Sorulan sorular arasında en yüksek puanları "Uygulamanın kullanımı hakkında yeterince bilgi sahibiyim", "Uygulamayı sürdürülebilir buluyorum" ve "Uygulamayı tavsiye ediyorum" soruları almış olup ortalama puan 4,58 (min:0 , maks: 5)’tür. Radyasyon onkolojisindeki uygulamalar, RT hastalarında özellikle gereksiz hasta transportunu önlemek için hasta bilgisi sağlama ve cihaz bilgisi paylaşma konusunda eksiktir. RT cihazları hakkında anında bilgi ve hastanın tanısına özgü bilgi, hastanın tedavi uyumu için çok önemlidir ve bunu iyileştirmek için uygulamalar geliştirilmelidir.

Anahtar Kelimeler

• mobil uygulama
• radyoterapi
• cihaz arızası
• anlık hasta bilgilendirmesi

Kaynakça

1. 1. Rades D, Zwaan I, Cacicedo J, Bruchhage KL, Hakim SG, Olbrich D, Schild SE, Tvilsted S, Janssen S. Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer - results of a randomized phase III trial (RAREST-02). BMC Cancer. 2022 Sep 17;22(1):989.
2. 2. Park J, Yea JW, Oh SA, Park JW. Efficacy of an Integrated Mobile Application System for Patients with Radiation Therapy: A Pilot Study. Healthcare (Basel). 2022 Sep 5;10(9):1696.
3. 3. Rades D, Narvaez CA, Doemer C, Janssen S, Olbrich D, Tvilsted S, Conde-Moreno AJ, Cacicedo J. Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis. Trials. 2020 May 25;21(1):424.
4. 4. Beckett M, Goethals L, Kraus RD, Denysenko K, Barone Mussalem Gentiles MF, Pynda Y, Abdel-Wahab M. Proximity to Radiotherapy Center, Population, Average Income, and Health Insurance Status as Predictors of Cancer Mortality at the County Level in the United States. JCO Glob Oncol. 2023 Sep;9:e2300130.
5. 5. El-Sayed, N Nelson: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomised trials. J Clin Oncol. 14:838-847 1996.
6. 6. Calero JJ, Oton LF, Oton CA. Apps for Radiation Oncology. A Comprehensive Review. Transl Oncol. 2017 Feb;10(1):108-114.
7. 7. http://www.asco.org/mobile-applications.
8. 8. De Rosa A (2014). “10 Best Oncology Apps.” Canc Netw [Web, URL http://www. cancernetwork.com/blog/10-best-oncology-apps].

9. 9. Thompson MA (2012). “Oncology Smartphone Applications: Perspectives From a Researcher/Community-Based Hematologist/Oncologist and a Physician Reviewer of Medical Apps.” Canc Netw [Web, URL http://www.cancernetwork.com/practice policy/oncology-smartphone-applications-perspectives-researchercommunity-based hematologistoncologist-and].
10. 10. iPhone Apps for Oncologists. The Association of Cancer Physicians; 2010 [Updated 20 March 2012, Web,URL http://www.cancerphysicians.org.uk/ resources/6-computingand-it/57-iphone-apps-for-oncologists.html].
11. 11. Collado-Borrell R, Escudero-Vilaplana V, Ribed-Sanchez A, et al. Smartphone applications for cancer patients; what we know about them? Farm Hosp. 2016;40:25-35.
12. 12. Alexandre NMC, Gallasch CH, Lima MHM, Rodrigues RCM. Reliability in the development and evaluation of measurement instruments in the health field. Rev Eletr Enferm. 2013;15(3):802-9.
13. 13. Janssen S, El Shafie RA, Ruder AM, Buergy D, Scafa D, Giordano FA, Nicolay NH, Vogel MME, Combs SE, Fahlbusch FB, Rades D, Käsmann L. Mobile applications in radiation oncology-current choices and future potentials. Strahlenther Onkol. 2023 Apr;199(4):337-349.
14. 14. Kessel KA, Vogel MME, Schmidt-Graf F, Combs SE (2016) Mobile apps in oncology: A survey on health care professionals’ attitude toward telemedicine, mhealth, and oncological apps. J Med Internet Res 18(11):e312.
15. 15. Kessel KA, Vogel MM, Kessel C, Bier H, Biedermann T, Friess H, Herschbach P, von Eisenhart-Rothe R, Meyer B, Kiechle M, Keller U, Peschel C, Schmid RM, Combs SE (2017) Mobile health in oncology: A patient survey about app-assisted cancer care. JMIR Mhealth Uhealth 5(6):e81–14.
16. 16. El Shafie RA, Weber D, Bougatf N, Sprave T, Oetzel D, Huber PE, Debus J, Nicolay NH (2018) Supportive care in radiotherapy based on a mobile app: Prospective multicenter survey. JMIR Mhealth Uhealth 6(8):e10916–30.
17. 17. Cannon C. Telehealth, Mobile Applications, and Wearable Devices are Expanding Cancer Care Beyond Walls. Semin Oncol Nurs. 2018 May;34(2):118-125.
18. 18. Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249.
19. 19. Denis, F.; Viger, L.; Charron, A.; Voog, E.; Dupuis, O.; Pointreau, Y.; Letellier, C. Detection of lung cancer relapse using selfreported symptoms transmitted via an internet web-application: Pilot study of the sentinel follow-up. Support. Care Cancer 2014, 22, 1467–1473.
20. 20. Denis, F.; Yossi, S.; Septans, A.L.; Charron, A.; Voog, E.; Dupuis, O.; Ganem, G.; Pointreau, Y.; Letellier, C. Improving Survival in Patients Treated for a Lung Cancer Using Self-Evaluated Symptoms Reported Through a Web Application. Am. J. Clin. Oncol. 2017, 40, 464–469.
21. 21. El Shafie, R.A.; Bougatf, N.; Sprave, T.; Weber, D.; Oetzel, D.; Machmer, T.; Huber, P.E.; Debus, J.; Nicolay, N.H. Oncologic Therapy Support Via Means of a Dedicated Mobile App (OPTIMISE-1): Protocol for a Prospective Pilot Trial. JMIR Res. Protoc. 2018, 7, e70.
22. 22. Ataei, G.; Cham, S.; Niksirat, F.; Shabestani Monfared, A.; Ebrahimnejad, G.K. Developing a Mobile Phone Application for Common Radiotherapy Calculations. J. Biomed Phys. Eng. 2020, 10, 235–240.
23. 23. Rades, D.; Narvaez, C.A.; Doemer, C.; Janssen, S.; Olbrich, D.; Tvilsted, S.; Conde- Moreno, A.J.; Cacicedo, J. Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis. Trials 2020, 21, 424.
24. 24. Zini, E.M.; Lanzola, G.; Quaglini, S.; Bossi, P.; Licitra, L.; Resteghini, C. A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy. Int. J. Med. Inform. 2019, 129, 404–412.
25. 25. Sethukavalan P, Cheung P, Tang CI, et al: Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: The benefits of hypofractionated over conventionallyfractionated radiotherapy. Can J Urol 19:6165-6169, 2012